GE Healthcare's Technetium [99mTc] tiludronate injection officially entered the national medical insurance catalog.

On December 9th, GE Healthcare announced that technetium [99mTc] tetrofosmin injection was officially included in the national medical insurance catalog, becoming the first diagnostic nuclear medicine to enter the medical insurance catalog through national negotiation. This drug is used for cardiac nuclear medicine examinations.